AUCKLAND, New Zealand, May 11, 2021 /PRNewswire/ -- Objective Acuity ("OAL") today announced the completion of a pilot study using OAL's threshold visual acuity test for young children diagnosed with late-infantile neuronal ceroid lipofuscinosis Type 2 (CLN2 disease), a form of Batten disease.

A prominent feature of CLN2 disease is vision...